Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6375257rdf:typepubmed:Citationlld:pubmed
pubmed-article:6375257lifeskim:mentionsumls-concept:C0030940lld:lifeskim
pubmed-article:6375257lifeskim:mentionsumls-concept:C1564378lld:lifeskim
pubmed-article:6375257lifeskim:mentionsumls-concept:C0079411lld:lifeskim
pubmed-article:6375257pubmed:dateCreated1984-7-23lld:pubmed
pubmed-article:6375257pubmed:abstractTextThe formation of EAC 4b2a is a two step reaction: first, the temperature- and time-independent binding of C2 to EAC4b2a resulting in EAC4b2 , secondly, the enzymatically triggered conversion of EAC4b2 to EAC4b2a . In the classical cascade of complement activation, the generation of C3 convertase activity is triggered by the C1 esterase, C1-s, which is part of C-1. Evidence is presented that the enzymes trypsin, chymotrypsin, plasmin, and pronase are also able to activate EAC4b2 to EAC4b2a . Kinetic studies showed that the formation of C3 convertase by these enzymes was dependent on concentration, temperature, and time. The optimal conditions were found as follows: trypsin, 2 micrograms/ml (final conc.) for 8 min at 23 degrees C; chymotrypsin 165 micrograms/ml for 18 min at 23 degrees C; plasmin 0.8 units/ml for 15 min at 23 degrees C; pronase 1.25 microgram/ml for 15 min at 23 degrees C. Even under optimal (tmax) conditions the number of generated EAC4b2a differed from enzyme to enzyme: trypsin (= 100%), pronase (58.3%), chymotrypsin (47.9%), and plasmin (12.9%). The enzymes were also able to generate C3 convertase activity from C2 which was adsorbed to EAC1i4b , a C1 inactivator treated and therefore hemolytically inactive intermediate ( EAC1i4b2 ). These findings underline the biological importance of C1 esterase replacing enzymes.lld:pubmed
pubmed-article:6375257pubmed:languageenglld:pubmed
pubmed-article:6375257pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6375257pubmed:citationSubsetIMlld:pubmed
pubmed-article:6375257pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6375257pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6375257pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6375257pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6375257pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6375257pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6375257pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6375257pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6375257pubmed:statusMEDLINElld:pubmed
pubmed-article:6375257pubmed:issn0108-0172lld:pubmed
pubmed-article:6375257pubmed:authorpubmed-author:LoosMMlld:pubmed
pubmed-article:6375257pubmed:authorpubmed-author:HeinzH PHPlld:pubmed
pubmed-article:6375257pubmed:issnTypePrintlld:pubmed
pubmed-article:6375257pubmed:volume284lld:pubmed
pubmed-article:6375257pubmed:ownerNLMlld:pubmed
pubmed-article:6375257pubmed:authorsCompleteYlld:pubmed
pubmed-article:6375257pubmed:pagination67-74lld:pubmed
pubmed-article:6375257pubmed:dateRevised2008-2-12lld:pubmed
pubmed-article:6375257pubmed:meshHeadingpubmed-meshheading:6375257-...lld:pubmed
pubmed-article:6375257pubmed:meshHeadingpubmed-meshheading:6375257-...lld:pubmed
pubmed-article:6375257pubmed:meshHeadingpubmed-meshheading:6375257-...lld:pubmed
pubmed-article:6375257pubmed:meshHeadingpubmed-meshheading:6375257-...lld:pubmed
pubmed-article:6375257pubmed:meshHeadingpubmed-meshheading:6375257-...lld:pubmed
pubmed-article:6375257pubmed:meshHeadingpubmed-meshheading:6375257-...lld:pubmed
pubmed-article:6375257pubmed:meshHeadingpubmed-meshheading:6375257-...lld:pubmed
pubmed-article:6375257pubmed:meshHeadingpubmed-meshheading:6375257-...lld:pubmed
pubmed-article:6375257pubmed:meshHeadingpubmed-meshheading:6375257-...lld:pubmed
pubmed-article:6375257pubmed:meshHeadingpubmed-meshheading:6375257-...lld:pubmed
pubmed-article:6375257pubmed:meshHeadingpubmed-meshheading:6375257-...lld:pubmed
pubmed-article:6375257pubmed:meshHeadingpubmed-meshheading:6375257-...lld:pubmed
pubmed-article:6375257pubmed:meshHeadingpubmed-meshheading:6375257-...lld:pubmed
pubmed-article:6375257pubmed:meshHeadingpubmed-meshheading:6375257-...lld:pubmed
pubmed-article:6375257pubmed:year1984lld:pubmed
pubmed-article:6375257pubmed:articleTitleGeneration of the classical pathway C3 convertase (EAC4b2a) by proteolytic enzymes.lld:pubmed
pubmed-article:6375257pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6375257pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:6375257pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:6375257pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed